Search

everythinglearnresearchcommunity

for

Search:↓

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

AGA treated with finasteride, minoxidil, and hair transplantation.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Hair transplants are effective for some women and many male-to-female transgender patients if done carefully by an experienced team.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

A gene mutation in mice causes permanent hair loss and skin issues.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.